Company: ZLAB
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001628280-25-020478
Chunk: 65

Company: Zai Lab Ltd
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 65
---
     |         |     |        |     |   |        |     |   |       |     |           |     |           |     |  21,435 |     | $ |   561,383 |     |        |     |   |         |
|                 |     | 4/1/2024  |     |           |     |      — |     |        |     | 197,306 |     |        |     | $ |  16.72 |     |   |       |     | 3/31/2034 |     |           |     |         |     |   |           |     |        |     |   |         |
|                 |     | 4/1/2024  |     |           |     |        |     |        |     |         |     |        |     |   |        |     |   |       |     |           |     |           |     | 128,249 |     | $ | 3,358,841 |     |        |     |   |         |

(1) The stock options are exercisable for ADSs, and each of the stock awards represents a contingent right to receive one ADS. As a result, the number of shares and exercise price in these columns are represented in terms of ADSs. Each ADS represents ten ordinary shares.

(2) Option awards have a maximum term of ten years from the grant date and vest in equal annual installments over five years, beginning on the first anniversary of the grant date, subject to the executive remaining in continuous service with us on each such vesting date, other than (i) the option award granted to Dr. Chen on November 1, 2021, and (ii) the option awards granted on or after April 3, 2023, which vest in equal annual installments over four years, beginning on the first anniversary of the grant date, subject to the executive remaining in continuous service with us on the vesting date.

(3) Restricted share awards and restricted share unit awards vest in equal annual installments over five years, beginning on the first anniversary of the grant date, subject to the executive remaining in continuous service with us on the vesting date, other than (i) the restricted share unit awards granted on June 25, 2022, (ii) the restricted share award granted to Dr. Chen on November 1, 2021, and (iii) the restricted share awards granted